Internal Medicine, Rheumatology · Plymouth, MA
NPI
1811157522
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
110 Long Pond Rd, Suite 106
Plymouth, MA, 02360
Phone (508) 746-5351
Groups this clinician bills Medicare through
Medicare paid, 2024
$725K
99,955 services
Medicare patients, 2024
891
Average age 75
Drug cost, 2024
$6.7M
4,983 prescriptions
Company payments, 2025
$5,820
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel L Gross was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 72,400 times for 21 patients. In total Rachel L Gross billed 99,955 services in 92 codes, and Medicare paid $725K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-13.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 72,400 | 21 | $3.61 | $262K |
| J0897 Injection, denosumab, 1 mg | Office | 9,900 | 97 | $20.40 | $202K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,320 | 14 | $0.10 | $138 |
| 36415 Venipuncture Blood Collection | Office | 1,182 | 578 | $8.65 | $10K |
| 99214 Office E&M - Established | Office | 1,046 | 619 | $90.22 | $94K |
| 82565 Clinical Chemistry | Office | 825 | 433 | $5.00 | $4,126 |
| 86140 Clinical Chemistry | Office | 636 | 339 | $5.08 | $3,231 |
| 85025 Blood Count | Office | 613 | 281 | $7.57 | $4,641 |
| 80076 Clinical Chemistry | Office | 584 | 269 | $7.97 | $4,653 |
| 85651 Clinical Chemistry | Office | 445 | 225 | $4.18 | $1,860 |
| 96372 Injection Administration | Office | 410 | 125 | $11.52 | $4,722 |
| 82306 Clinical Chemistry | Office | 291 | 204 | $29.01 | $8,442 |
| 82310 Clinical Chemistry | Office | 274 | 187 | $5.06 | $1,386 |
| 99213 Office E&M - Established | Office | 243 | 223 | $64.86 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 210 | 194 | $13.05 | $2,741 |
By year: 2022 $647K for 83,353 services; 2023 $660K for 90,459 services; 2024 $725K for 99,955 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,182 | 578 | $8.65 | $10K |
| 82565 Clinical Chemistry | 825 | 433 | $5.00 | $4,126 |
| 86140 Clinical Chemistry | 636 | 339 | $5.08 | $3,231 |
| 85025 Blood Count | 613 | 281 | $7.57 | $4,641 |
| 80076 Clinical Chemistry | 584 | 269 | $7.97 | $4,653 |
| 85651 Clinical Chemistry | 445 | 225 | $4.18 | $1,860 |
| 82306 Clinical Chemistry | 291 | 204 | $29.01 | $8,442 |
| 82310 Clinical Chemistry | 274 | 187 | $5.06 | $1,386 |
| 86160 Immunoassay | 152 | 61 | $11.64 | $1,769 |
| 86235 Immunoassay | 132 | 37 | $17.36 | $2,292 |
Medicare prescription drug claims, 2024
In 2024, the drug Rachel L Gross prescribed most often to Medicare patients was Prednisone, with 824 prescriptions and refills. In total Rachel L Gross wrote 4,983 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 824 | 1,331 | 181 | $5,825 |
| Methotrexate Methotrexate Sodium | 748 | 1,466 | 159 | $18K |
| Hydroxychloroquine Sulfate Generic | 520 | 1,211 | 125 | $20K |
| Allopurinol Generic | 276 | 774 | 72 | $3,375 |
| Alendronate Sodium Generic | 247 | 508 | 62 | $5,165 |
| Humira(Cf) Pen Adalimumab | 154 | 170 | 28 | $1.3M |
| Leflunomide Generic | 148 | 326 | 40 | $15K |
| Tramadol Hcl Generic | 137 | 137 | 16 | $646 |
| Enbrel Sureclick Etanercept | 118 | 138 | 15 | $949K |
| Gabapentin Generic | 114 | 186 | 22 | $3,367 |
| Folic Acid Generic | 97 | 252 | 27 | $748 |
| Otezla Apremilast | 84 | 84 | Under 11 | $368K |
| Leucovorin Calcium Generic | 75 | 178 | 19 | $1,014 |
| Taltz Autoinjector Ixekizumab | 70 | 74 | Under 11 | $572K |
| Sulfasalazine Generic | 59 | 139 | 14 | $1,709 |
Brand drugs: - claims; generic drugs: 3,840 claims; opioid claims: 173.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachel L Gross $5,820 ($5,820 in general payments such as food, travel and fees) from 1 company. The largest payer was E.R. Squibb & Sons, L.L.C. with $5,820.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $5,820 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.